{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:48:35Z","timestamp":1790394515771,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,6]],"date-time":"2011-10-06T00:00:00Z","timestamp":1317859200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by abdominal pain and change of bowel habits without organic disease. Many patients seek alternative IBS treatments because of the limitations of conventional treatments. <jats:italic>Gwakhyangjeonggisan<\/jats:italic> (GJS), a herbal formula, has long been used for alleviating diarrhea-predominant IBS (D-IBS) in traditional medicine. Duolac7S, which comprises 7 bacterial species as probiotics, has been frequently used for D-IBS. Although GJS and Duolac7S have been administered simultaneously in many D-IBS patients, no study has investigated the effects of GJS and Duolac7S combination therapy on D-IBS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/Design<\/jats:title>\n            <jats:p>The current trial is a randomized, double-blinded, placebo-controlled, 4-arm study. After a 2-week run-in period, 60 patients with D-IBS will be randomly assigned to one of the 4 combination groups consisting of GJS (water extract granules, 3 g\/pack, 3 times a day) with Duolac7S (powder form, 1 capsule, 2 times a day) or their placebos and followed up for 2 weeks. The assigned treatments will last for 8 weeks. The primary outcomes are adequate relief of IBS pain and discomfort and the proportion of responders (on a weekly basis). The secondary outcomes are visual analog scale for IBS symptoms (on a daily basis), quality of life (at 0, 8, and 10 weeks), intestinal permeability, and composition of intestinal microbiota (at 0 and 8 weeks).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The present study is designed to examine the safety and efficacy of GJS and Duolac7S combination therapy on D-IBS. Our study provides the clinical evidence of a new therapeutic strategy for D-IBS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ClinicalTrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01342718\" ext-link-type=\"uri\">NCT01342718<\/jats:ext-link>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1745-6215-12-219","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T18:43:42Z","timestamp":1319222622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Seok-Jae","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongha","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom-Gi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inkwon","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,6]]},"reference":[{"key":"747_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/bmj.332.7536.280","volume":"332","author":"A Agrawal","year":"2006","unstructured":"Agrawal A, Whorwell PJ: Irritable bowel syndrome: diagnosis and management. BMJ. 2006, 332: 280-283. 10.1136\/bmj.332.7536.280.","journal-title":"BMJ"},{"key":"747_CR2","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1053\/gast.1997.v112.agast972120","volume":"112","author":"DA Drossman","year":"1997","unstructured":"Drossman DA, Whitehead WE, Camilleri M: Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997, 112: 2120-2137. 10.1053\/gast.1997.v112.agast972120.","journal-title":"Gastroenterology"},{"key":"747_CR3","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology. 2006, 130: 1480-1491. 10.1053\/j.gastro.2005.11.061.","journal-title":"Gastroenterology"},{"key":"747_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.7326\/0003-4819-133-2-200007180-00013","volume":"133","author":"J Jailwala","year":"2000","unstructured":"Jailwala J, Imperiale TF, Kroenke K: Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med. 2000, 133: 136-147.","journal-title":"Ann Intern Med"},{"key":"747_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1248\/yakushi.126.1185","volume":"126","author":"K Li","year":"2006","unstructured":"Li K, Yuan J, Su W: Determination of liquiritin, naringin, hesperidin, thymol, imperatorin, honokiol, isoimperatorin, and magnolol in the traditional Chinese medicinal preparation Huoxiang-zhengqi liquid using high-performance liquid chromatography. Yakugaku Zasshi. 2006, 126: 1185-1190. 10.1248\/yakushi.126.1185.","journal-title":"Yakugaku Zasshi"},{"key":"747_CR6","first-page":"456","volume":"29","author":"YC Xie","year":"2004","unstructured":"Xie YC, Tang F: Experimental study on protecting intestinal barrier function of Huoxiang Zhengqi soft capsule. Zhongguo Zhong Yao Za Zhi. 2004, 29: 456-458.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"747_CR7","first-page":"137","volume":"16","author":"LI Kang","year":"2010","unstructured":"Kang LI, Chen SL, Zhou WL, Wang YY: Mechanism of effect of Huoxiang Zhengqi liquid on the spontaneous contraction of colonic muscle from mice. Chin J Exp Trad Med Formulae. 2010, 16: 137-140.","journal-title":"Chin J Exp Trad Med Formulae"},{"key":"747_CR8","doi-asserted-by":"publisher","first-page":"7346","DOI":"10.3748\/wjg.v12.i45.7346","volume":"12","author":"YH He","year":"2006","unstructured":"He YH, Zhao HY, Liu ZL, Lu C, Luo XJ, Lin SQ, Qian XW, Chen SL, Lu AP: Effects of huoxiangzhengqi liquid on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrhea. World J Gastroenterol. 2006, 12: 7346-7349.","journal-title":"World J Gastroenterol"},{"key":"747_CR9","first-page":"11","volume":"10","author":"YB Kim","year":"1993","unstructured":"Kim YB, Kim JH, Chae BY: Effects on Koakhyangieonggisan and Gamikoahyangieonggisan on the digestive and anti-allergic function. Korean J Orient Med Soc. 1993, 10: 11-23.","journal-title":"Korean J Orient Med Soc"},{"key":"747_CR10","volume-title":"KyungHee Orient Med Coll J","author":"KW Ryu","year":"1998","unstructured":"Ryu KW, Ryu BH, Yun HS, Park DW: Experimental comparative studies on the effects of Kwakhyangjeonggisan and Souminkwakhyang-jeonggisan. KyungHee Orient Med Coll J. 1998, 21:"},{"key":"747_CR11","first-page":"889","volume":"26","author":"JH Han","year":"2005","unstructured":"Han JH, Kim GB, Han IS, Shim YS, Kim EG: A clinical report of chronic diarrhea treated with GwakHyang-JungGiSan. Korean J Orient Int Med. 2005, 26: 889-896.","journal-title":"Korean J Orient Int Med"},{"key":"747_CR12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jn\/130.2.396S","volume":"130","author":"RD Rolfe","year":"2000","unstructured":"Rolfe RD: The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000, 130: 396-402.","journal-title":"J Nutr"},{"key":"747_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/187152309789151977","volume":"8","author":"EO Petrof","year":"2009","unstructured":"Petrof EO: Probiotics and gastrointestinal disease: clinical evidence and basic science. Antiinflamm Antiallergy Agents Med Chem. 2009, 8: 260-269. 10.2174\/187152309789151977.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"747_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-230X-9-15","volume":"9","author":"N Hoveyda","year":"2009","unstructured":"Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P: A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009, 9: 15-10.1186\/1471-230X-9-15.","journal-title":"BMC Gastroenterol"},{"key":"747_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MOG.0b013e32831b4455","volume":"25","author":"A Guarino","year":"2009","unstructured":"Guarino A, Lo Vecchio A, Canani RB: Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol. 2009, 25: 18-23. 10.1097\/MOG.0b013e32831b4455.","journal-title":"Curr Opin Gastroenterol"},{"key":"747_CR16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1152\/ajpgi.00202.2007","volume":"294","author":"A Seth","year":"2008","unstructured":"Seth A, Yan F, Polk DB, Rao RK: Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2008, 294: 1060-1069. 10.1152\/ajpgi.00202.2007.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"747_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/MCG.0b013e3181574393","volume":"42","author":"M Camilleri","year":"2008","unstructured":"Camilleri M: Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol. 2008, 42: 123-125.","journal-title":"J Clin Gastroenterol"},{"key":"747_CR18","unstructured":"Korean Food and Drug Administration.http:\/\/www.kfda.go.kr\/index.jsp"},{"key":"747_CR19","unstructured":"Herbal formula and lactic acid bacteria. http:\/\/www.akomnews.com\/subpage\/search_detail.php?code=A001&uid=53825&page=\/subpage\/search.php&nowpage=1&search_word"},{"key":"747_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1046\/j.1365-2036.2003.01543.x","volume":"17","author":"HJ Kim","year":"2003","unstructured":"Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR: A randomized controlled trial of a porbiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003, 17: 895-904. 10.1046\/j.1365-2036.2003.01543.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"747_CR21","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW: Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997, 32: 920-924. 10.3109\/00365529709011203.","journal-title":"Scand J Gastroenterol"},{"key":"747_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2982.2005.00695.x","volume":"17","author":"HJ Kim","year":"2005","unstructured":"Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR: A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005, 17: 687-696. 10.1111\/j.1365-2982.2005.00695.x.","journal-title":"Neurogastroenterol Motil"},{"key":"747_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/gast.2000.8553","volume":"119","author":"B Coulie","year":"2000","unstructured":"Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N, Cedarbaum JM: Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology. 2000, 119: 41-50. 10.1053\/gast.2000.8553.","journal-title":"Gastroenterology"},{"key":"747_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1572-0241.2000.01941.x","volume":"95","author":"DA Drossman","year":"2000","unstructured":"Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, Jia H, Bangdiwala SI: Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000, 95: 999-1007. 10.1111\/j.1572-0241.2000.01941.x.","journal-title":"Am J Gastroenterol"},{"key":"747_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11894-999-0023-5","volume":"1","author":"D Hollander","year":"1999","unstructured":"Hollander D: Intestinal permeability, leaky gut and intestinal disorders. Curr Gastroenterol Rep. 1999, 1: 410-416. 10.1007\/s11894-999-0023-5.","journal-title":"Curr Gastroenterol Rep"},{"key":"747_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pain.2009.06.017","volume":"146","author":"Q Zhou","year":"2009","unstructured":"Zhou Q, Zhang B, Verne GN: Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain. 2009, 146: 41-46. 10.1016\/j.pain.2009.06.017.","journal-title":"Pain"},{"key":"747_CR27","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/S0002-9270(03)00703-2","volume":"98","author":"V Di Leo","year":"2003","unstructured":"Di Leo V, D'Inc\u00e0 R, Diaz-Granado N, Fries W, Venturi C, D'Odorico A, Martines D, Sturniolo GC: Lactulose\/mannitol test has high efficacy for excluding organic causes of chronic diarrhea. Am J Gastroenterol. 2003, 98: 2245-2252.","journal-title":"Am J Gastroenterol"},{"key":"747_CR28","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/0016-5085(95)90708-4","volume":"108","author":"I Bjarnason","year":"1995","unstructured":"Bjarnason I, MacPherson A, Hollander D: Intestinal permeability: an overview. Gastroenterology. 1995, 108: 1566-1581. 10.1016\/0016-5085(95)90708-4.","journal-title":"Gastroenterology"},{"key":"747_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/j.1572-0241.2006.00672.x","volume":"101","author":"SP Dunlop","year":"2006","unstructured":"Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC: Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006, 101: 1288-1294. 10.1111\/j.1572-0241.2006.00672.x.","journal-title":"Am J Gastroenterol"},{"key":"747_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2982.2007.00925.x","volume":"19","author":"M Camilleri","year":"2007","unstructured":"Camilleri M, Gorman H: Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007, 19: 545-552. 10.1111\/j.1365-2982.2007.00925.x.","journal-title":"Neurogastroenterol Motil"},{"key":"747_CR31","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.3748\/wjg.v16.i36.4532","volume":"16","author":"E Malinen","year":"2010","unstructured":"Malinen E, Krogius-Kurikka L, Lyra A, Nikkil\u00e4 J, J\u00e4\u00e4skel\u00e4inen A, Rinttil\u00e4 T, Vilpponen-Salmela T, von Wright AJ, Palva A: Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol. 2010, 16: 4532-4540. 10.3748\/wjg.v16.i36.4532.","journal-title":"World J Gastroenterol"},{"key":"747_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1472-765X.2010.02915.x","volume":"51","author":"C Wang","year":"2010","unstructured":"Wang C, Nishino N: Presence of sourdough lactic acid bacteria in commercial total mixed ration silage as revealed by denaturing gradient gel electrophoresis analysis. Lett Appl Microbiol. 2010, 51: 436-442. 10.1111\/j.1472-765X.2010.02915.x.","journal-title":"Lett Appl Microbiol"},{"key":"747_CR33","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/gut.27.7.826","volume":"27","author":"HL Smart","year":"1986","unstructured":"Smart HL, Mayberry JF, Atkinson M: Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut. 1986, 27: 826-828. 10.1136\/gut.27.7.826.","journal-title":"Gut"},{"key":"747_CR34","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1111\/j.1572-0241.2006.00576.x","volume":"101","author":"WK Leung","year":"2006","unstructured":"Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ: Treatment of diarrhea predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial. Am J Gastroenterol. 2006, 101: 1574-1580. 10.1111\/j.1572-0241.2006.00576.x.","journal-title":"Am J Gastroenterol"},{"key":"747_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1440-1754.2007.01076.x","volume":"43","author":"DA Lemberg","year":"2007","unstructured":"Lemberg DA, Ooi CY, Day AS: Probiotics in paediatric gastrointestinal diseases. J Paediatr Child Health. 2007, 43: 331-336. 10.1111\/j.1440-1754.2007.01076.x.","journal-title":"J Paediatr Child Health"},{"key":"747_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","volume":"128","author":"L O'Mahony","year":"2005","unstructured":"O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM: Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005, 128: 541-551. 10.1053\/j.gastro.2004.11.050.","journal-title":"Gastroenterology"},{"key":"747_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1590-8658(07)60007-3","volume":"38","author":"M Camilleri","year":"2006","unstructured":"Camilleri M: Is there a role for probiotics in irritable bowel syndrome?. Dig Liver Dis. 2006, 38: 266-269.","journal-title":"Dig Liver Dis"},{"key":"747_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1440-1746.2004.03181.x","volume":"19","author":"S Pathmakanthan","year":"2004","unstructured":"Pathmakanthan S, Li CK, Cowie J, Hawkey CJ: Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol Hepatol. 2004, 19: 166-173. 10.1111\/j.1440-1746.2004.03181.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"747_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/gut.2003.026252","volume":"53","author":"S M\u00e9nard","year":"2004","unstructured":"M\u00e9nard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M: Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut. 2004, 53: 821-828. 10.1136\/gut.2003.026252.","journal-title":"Gut"},{"key":"747_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-010-0166-z","volume":"50","author":"CM Chapman","year":"2011","unstructured":"Chapman CM, Gibson GR, Rowland I: Health benefits of probiotics: are mixtures more effective than single strains?. Eur J Nutr. 2011, 50: 1-17. 10.1007\/s00394-010-0166-z.","journal-title":"Eur J Nutr"},{"key":"747_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1365-2036.2007.03542.x","volume":"27","author":"K Kajander","year":"2008","unstructured":"Kajander K, Myllyluoma E, Rajili\u0107-Stojanovi\u0107 M, Kyr\u00f6npalo S, Rasmussen M, J\u00e4rvenp\u00e4\u00e4 S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R: Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther. 2008, 27: 48-57.","journal-title":"Aliment Pharmacol Ther"},{"key":"747_CR42","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3748\/wjg.v10.i12.1802","volume":"10","author":"JM Si","year":"2004","unstructured":"Si JM, Yu YC, Fan YJ, Chen SJ: Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol. 2004, 10: 1802-1805.","journal-title":"World J Gastroenterol"},{"key":"747_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.femsim.2004.08.009","volume":"43","author":"J M\u00e4tt\u00f6","year":"2005","unstructured":"M\u00e4tt\u00f6 J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M: Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol. 2005, 43: 213-222. 10.1016\/j.femsim.2004.08.009.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"747_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","volume":"133","author":"A Kassinen","year":"2007","unstructured":"Kassinen A, Krogius-Kurikka L, M\u00e4kivuokko H, Rinttil\u00e4 T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A: The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007, 133: 24-33. 10.1053\/j.gastro.2007.04.005.","journal-title":"Gastroenterology"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-12-219\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:23:06Z","timestamp":1630516986000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-12-219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-12-219","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,6]]},"assertion":[{"value":"12 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"219"}}